30.30
0.98%
-0.30
Tectonic Therapeutic Inc (TECX) 最新ニュース
Navigating Uncertainty: Tectonic Therapeutic’s Clinical Data Volatility and Its Impact on Business Stability - TipRanks
Timothy A. Springer Acquires 50,000 Shares of Tectonic Therapeutic (NASDAQ:TECX) Stock - Defense World
Tectonic Therapeutic director buys shares worth over $1.4 million - Investing.com
Tectonic Therapeutic director buys shares worth over $1.4 million By Investing.com - Investing.com UK
Tectonic Therapeutic (NASDAQ:TECX) Short Interest Update - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Sees Significant Growth in Short Interest - MarketBeat
Affinity Asset Advisors LLC Makes New Investment in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Affinity Asset Advisors LLC Makes New Investment in Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat
Farallon Capital Management LLC Makes New $7.10 Million Investment in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Farallon Capital Management LLC Makes New Investment in Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
Tectonic Therapeutics stock earns continued Overweight rating on catalyst-packed 12 months ahead - Investing.com Canada
Tectonic Therapeutics stock earns continued Overweight rating on catalyst-packed 12 months ahead - Investing.com
Tectonic Therapeutic (NASDAQ:TECX) Sees Large Volume Increase - MarketBeat
Tectonic reports positive Phase 1a results for heart treatment TX45 - Investing.com India
Tectonic reports positive Phase 1a results for heart treatment TX45 By Investing.com - Investing.com Australia
Tectonic Therapeutic reports findings from Phase Ia trial of TX45 - Yahoo Finance
Tectonic reports positive Phase 1a results for heart treatment TX45 - Investing.com
Tectonic Therapeutic (NASDAQ:TECX) Hits New 1-Year High at $19.88 - MarketBeat
Tectonic Therapeutic’s TX45 Shows Promise in Phase 1a Trial - TipRanks
Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45 - GlobeNewswire
Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45 - StockTitan
Tectonic Therapeutic (NASDAQ:TECX) Shares Gap Down to $18.65 - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Shares Gap Down to $18.65 - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Trading Down 2.9% - MarketBeat
Atlas Venture Life Science Advisors LLC Purchases New Stake in Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Short Interest Up 52.6% in August - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Shares Gap Up to $17.50 - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Stock Price Down 2.9% - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Short Interest Up 50.4% in August - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Sees Large Growth in Short Interest - Defense World
AVROBIO, Inc. announced that it has received $25.150002 million in funding from Atlas Venture L.P., SV Health Investors, LLC, Blackstone Life Sciences - Marketscreener.com
TECX Stock Earnings: Tectonic Therapeutic Misses EPS for Q2 2024 - InvestorPlace
Contrasting SpringWorks Therapeutics (NASDAQ:SWTX) and Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Shares Gap Up to $16.25 - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Coverage Initiated by Analysts at Wells Fargo & Company - MarketBeat
Tectonic stock wins bullish view at Wells Fargo (NASDAQ:TECX) - Seeking Alpha
Wells Fargo rates Tectonic Therapeutics shares Overweight, cites TX45's potential - Investing.com
Tectonic Therapeutic (NASDAQ:TECX) Research Coverage Started at Wells Fargo & Company - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Stock Quotes, Forecast and News Summary - Benzinga
Tectonic Therapeutic to Participate in September Investor Conferences - GlobeNewswire
Tectonic Therapeutic to Participate in September Investor Conferences - StockTitan
Tectonic Therapeutic to Participate in September Investor Conferences - Yahoo Finance
Q3 2024 Earnings Estimate for Tectonic Therapeutic Issued By Leerink Partnrs (NASDAQ:TECX) - MarketBeat
Leerink Partnrs Brokers Reduce Earnings Estimates for Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Sees Large Volume Increase - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Sees Strong Trading Volume - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Trading Up 4.6% - MarketBeat
Tectonic Therapeutic Announces Second Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewswire
Tectonic Therapeutic Announces Second Quarter 2024 Financial Results and Recent Business Highlights - StockTitan
Head to Head Contrast: Tectonic Therapeutic (TECX) & Its Competitors - Defense World
Reviewing VectivBio (NASDAQ:VECT) & Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Tectonic Therapeutic: Analyzing Its Post-Merger Valuation And Prospects - Seeking Alpha
July M&A deals: Eli Lilly, Desktop Metal and Eastern Bank. - The Business Journals
Immatics Appoints Alise Reicin to Board of Directors - GlobeNewswire
Immatics Appoints Alise Reicin to Board of Directors - Yahoo Finance UK
Tectonic Therapeutic Advances in Pulmonary Hypertension Trials - TipRanks
Tectonic Therapeutic Announces US IND Clearance for Lead Program, TX45 - GlobeNewswire
Tectonic Therapeutic Announces US IND Clearance for Lead Program, TX45 - StockTitan
How the (TECX) price action is used to our Advantage - Stock Traders Daily
Leerink Partnrs Comments on Tectonic Therapeutic’s Q3 2024 Earnings (NASDAQ:TECX) - Defense World
Equities Analysts Issue Forecasts for Tectonic Therapeutic's Q3 2024 Earnings (NASDAQ:TECX) - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Stock Rating Upgraded by Leerink Partnrs - MarketBeat
US Bancorp DE Buys 5,458 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO) - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Upgraded to “Strong-Buy” at Leerink Partnrs - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Raised to Strong-Buy at Leerink Partnrs - Defense World
大文字化:
|
ボリューム (24 時間):